    ADVERSE REACTIONS  

  Side effects most commonly reported were  drowsiness≠B-OSE_Labeled_AE ,  fatigue≠B-OSE_Labeled_AE ,  muscle≠B-OSE_Labeled_AE   weakness≠I-OSE_Labeled_AE , and  ataxia≠B-OSE_Labeled_AE . The following have also been reported:

     Central Nervous System:  

   confusion≠B-OSE_Labeled_AE ,  depression≠B-OSE_Labeled_AE ,  dysarthria≠B-OSE_Labeled_AE ,  headache≠B-OSE_Labeled_AE ,  slurred≠B-OSE_Labeled_AE   speech≠I-OSE_Labeled_AE ,  tremor≠B-OSE_Labeled_AE ,  vertigo≠B-OSE_Labeled_AE 

     Gastrointestinal System:  

   constipation≠B-OSE_Labeled_AE ,  nausea≠B-OSE_Labeled_AE ,  gastrointestinal≠B-OSE_Labeled_AE   disturbances≠I-OSE_Labeled_AE 

     Special Senses:  

   blurred≠B-OSE_Labeled_AE   vision≠I-OSE_Labeled_AE ,  diplopia≠B-OSE_Labeled_AE ,  dizziness≠B-OSE_Labeled_AE 

     Cardiovascular System:  

   hypotension≠B-OSE_Labeled_AE 

     Psychiatric and Paradoxical Reactions:  

   stimulation≠B-OSE_Labeled_AE ,  restlessness≠B-OSE_Labeled_AE ,  acute≠B-OSE_Labeled_AE   hyperexcited≠I-OSE_Labeled_AE   states≠I-OSE_Labeled_AE ,  anxiety≠B-OSE_Labeled_AE ,  agitation≠B-OSE_Labeled_AE ,  aggressiveness≠B-OSE_Labeled_AE ,  irritability≠B-OSE_Labeled_AE ,  rage≠B-OSE_Labeled_AE ,  hallucinations≠B-OSE_Labeled_AE ,  psychoses≠B-OSE_Labeled_AE ,  delusions≠B-OSE_Labeled_AE ,  increased≠B-OSE_Labeled_AE   muscle≠I-OSE_Labeled_AE   spasticity≠I-OSE_Labeled_AE ,  insomnia≠B-OSE_Labeled_AE ,  sleep≠B-OSE_Labeled_AE   disturbances≠I-OSE_Labeled_AE , and  nightmares≠B-OSE_Labeled_AE .  Inappropriate≠B-OSE_Labeled_AE   behavior≠I-OSE_Labeled_AE  and other  adverse≠B-OSE_Labeled_AE   behavioral≠I-OSE_Labeled_AE   effects≠I-OSE_Labeled_AE  have been reported when using benzodiazepines. Should these occur, use of the drug should be discontinued. They are more likely to occur in children and in the elderly.

     Urogenital System:  

   incontinence≠B-OSE_Labeled_AE ,  changes≠B-OSE_Labeled_AE   in≠I-OSE_Labeled_AE   libido≠I-OSE_Labeled_AE ,  urinary≠B-OSE_Labeled_AE   retention≠I-OSE_Labeled_AE 

     Skin and Appendages:  

   skin≠B-OSE_Labeled_AE   reactions≠I-OSE_Labeled_AE 

     Laboratories:  

   elevated≠B-OSE_Labeled_AE   transaminases≠I-OSE_Labeled_AE  and alkaline phosphatase

     Other:  

   changes≠B-OSE_Labeled_AE   in≠I-OSE_Labeled_AE   salivation≠I-OSE_Labeled_AE , including  dry≠B-OSE_Labeled_AE   mouth≠I-OSE_Labeled_AE ,  hypersalivation≠B-OSE_Labeled_AE 

  Antegrade≠B-OSE_Labeled_AE   amnesia≠I-OSE_Labeled_AE  may occur using therapeutic dosages, the risk increasing at higher dosages.  Amnestic≠B-OSE_Labeled_AE   effects≠I-OSE_Labeled_AE  may be associated with  inappropriate≠B-OSE_Labeled_AE   behavior≠I-OSE_Labeled_AE .

 Minor  changes≠B-OSE_Labeled_AE   in≠I-OSE_Labeled_AE   EEG≠I-OSE_Labeled_AE  patterns, usually low-voltage fast activity, have been observed in patients during and after Valium therapy and are of no known significance.

 Because of isolated reports of  neutropenia≠B-OSE_Labeled_AE  and  jaundice≠B-OSE_Labeled_AE , periodic blood counts and liver function tests are advisable during long-term therapy.

   Postmarketing Experience

  Injury, Poisoning and Procedural Complications

  There have been reports of  falls≠B-OSE_Labeled_AE  and  fractures≠B-OSE_Labeled_AE  in benzodiazepine users. The risk is increased in those taking concomitant sedatives (including alcohol), and in the elderly.

